Save the date! 37th Annual scientific meeting: September 22-24, 2023
Save the date! 37th Annual scientific meeting: September 22-24, 2023
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Saturday October 8th- Calloway Room
Dr. Alan Brown "The Benefit Risk Dialogue: A Deep Dive into Efficacy and Safety Data of a JAK Inhibitor Across Indications"
Contact Us: Phil McQuain | firstname.lastname@example.org
Aurinia is a biopharmaceutical company focused on developing therapies for patient populations impacted by serious diseases with a high unmet medical need. Aurinia received FDA approval for their first commercially available drug product in January 2021. Please visit www.AuriniaLN.com to learn more.
Saturday October 8th Break Sponsor
Christian Harriott | email@example.com
George Kilbourne | firstname.lastname@example.org
Frank Bartram | email@example.com
Jason Plant | firstname.lastname@example.org
Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions.
Sarah Knight | email@example.com
John Bench | firstname.lastname@example.org
Melissa Tinger | email@example.com
ChemoCentryx is a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally administered therapies.
Susan Malone | firstname.lastname@example.org | 540-461-0517
Kelechi Arungwa | email@example.com | 301-437-4506
We’re pursuing bold advancements in medicine and pushing to close gaps in health care inequality. We’re finding new paths that may lead to the next big breakthroughs, while embracing the diverse perspectives that advance our innovation. But no matter what we’re focused on, we never lose sight of why we’re working—to make life better for people around the world.
Natalia Croly | firstname.lastname@example.org
Exagen Inc. is a patient-focused and discovery-driven commercial-stage life sciences company. We aid patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. Our relentless pursuit for laboratory excellence has enabled us to develop next-generation autoimmune testing to help empower physicians and improve patients’ lives.
Kevin Marven | email@example.com
Joe Walton | Jwalton@exagen.com
Maureen Pierson | firstname.lastname@example.org
GSK is a science-led global healthcare company with a special purpose: to help people. We research, develop, and manufacture innovative pharmaceutical, biological, vaccine, and consumer healthcare products in an effort to bring differentiated, high-quality products to the people who need them. Visit our website to learn more about our products, resources, and the science behind it all.
Monique Hunnicutt | email@example.com
Christina Spell | firstname.lastname@example.org
For decades, Janssen has been providing patients and physicians with important therapies to treat rheumatic diseases. We remain focused on complementing our existing portfolio of large-molecule biologics with novel treatments and oral therapeutics in development to provide new options to patients, through a combination of internal research and development, external collaborations, and industry consortia.
Sybille Jennings | email@example.com | 202-437-0067
Ronald Pendleton | firstname.lastname@example.org | 804-944-6727
Ann Powell | email@example.com | 540-312-3393
Jennifer Riccardi| firstname.lastname@example.org | 603-767-5258
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and potentially life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions. For more information, visit the Sanofi website.
Sunday, October 9th- Calloway Room
Dr. Aarat Patel "Cycle or Switch: Kevzara after TNFi Inadequate Response in Patients with RA"
Jill Callejas- email@example.com
Casey Valentine- firstname.lastname@example.org
UCB innovates and delivers solutions that make real improvements for people living with severe diseases. We partner with and listen to patients, caregivers and stakeholders across the healthcare system to identify promising innovations that create valuable health solutions.
Linda Morrell | email@example.com
Stephen Hawes | firstname.lastname@example.org
Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.
Christy Cooper | 804-874-9008
Brian Craig | 540-331-8694
Mike Robinson | 540-476-2757
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products.
Marisa Phillips | email@example.com
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Saturday, October 8th- Calloway Room
Gordon Lam, MD "An Overview of Systemic Lupus Erythematosus (SLE) Disease Burden, Assessment, and Treatment"
Melina Heitkamp | firstname.lastname@example.org
Kalyn Melanophy | email@example.com
BMS is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience.
Cherie Simon| firstname.lastname@example.org
Kiniksa is a global biopharmaceutical company that finds and delivers novel treatments for patients with significant unmet need. We are focused on building a better future for patients by developing a portfolio of differentiated therapies.
Sharla Kvasnicka | email@example.com
Novartis is a leading global medicines company, using innovative science and digital technologies to create treatments in areas of great medical need. About 108,000 people of more than 140 nationalities work at Novartis around the world. Find out more at http://www.novartis.us.
Joni Doran | firstname.lastname@example.org
Dave Beard | email@example.com
William Coble | firstname.lastname@example.org
Susan Marino | email@example.com
Website: Novartis Medical
Radius Health is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health and neuroscience. Our team works collaboratively and relentlessly to advance our therapies with the goal of improving the lives of patients, their families, and their caregivers.
CeCe Finan | firstname.lastname@example.org
Mari Bennett-Grames | email@example.com
Altus Biologics partners with physicians across multiple specialties to provide comprehensive, in-office infusion and subcutaneous injection services. At Altus Biologics, we are committed to improving access, quality of care and affordability for all patients.
Marty Kelleher | firstname.lastname@example.org
To promote the science and practice of rheumatology, foster the advancement and education of Women in Rheumatology, and advocate access to the highest quality health care, and management of patients with rheumatic diseases.
Bendcare provides services and technology solutions for specialty providers and patients on journey. Our company creates Healthier healthcare™ by returning control to physicians and patients, improving quality and outcomes resulting in cost-effective care.
Jillian DelGrosso | email@example.com
Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
Jonas Brinks | firstname.lastname@example.org
Elizabeth Vivelo | email@example.com
The Coalition of State Rheumatology Organizations (CSRO) is comprised of state and regional professional rheumatology societies whose mission is to advocate for excellence in the field of rheumatology, ensuring access to the highest quality care for patients.
Carly Uhlrich | firstname.lastname@example.org
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Andrew Anguiano | email@example.com
Tracy Gange | firstname.lastname@example.org
Kim Brown | email@example.com
Kevin Lin | firstname.lastname@example.org
Nufactor offers safe, convenient, and reliable infusion solutions for patients receiving immunoglobulin, antihemophilic factor, and infliximab. Count on us for high-quality therapies and individualized care—all in the comfort of your home.
Michelle Sipula | email@example.com
What's a product or service you'd like to show.
Scipher Medicine is a precision immunology company that matches each patient with their most effective treatment based on biology and scientific data. PrismRA® brings precision medicine to rheumatoid arthritis (RA) treatment. The PrismRA® Test provides insights that guide therapy selection and give patients their best opportunity to reach treatment goals.
James Sziksai | firstname.lastname@example.org
The Sjögren's Foundation provides credible resources and education for healthcare professionals; encourages and funds research to better understand, diagnose and treat Sjogren's; and supports patients through education, advocacy and services.
Matt Makara | email@example.com
As the North American affiliate of biopharmaceutical company Sobi™, our vision is to provide sustainable access to innovative therapies and transform the lives of people affected by rare diseases. Our product portfolio is focused on immunology and genetics/metabolism.
Al Johnson | firstname.lastname@example.org
TSI Healthcare is a national leader in the sales and support of customized NextGen® Practice Management and Electronic Health Record solutions. In addition to core products powered by NextGen®, we also offer Patient Portal, Population Health Management, Telehealth, Patient Engagement, Revenue Cycle Management, cloud hosting, and more.
Michael Chavez | email@example.com
@tsihealthcare on Instagram & Twitter